Article info
PDFLetter
ITPA genotyping test does not improve detection of Crohn’s disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression
- Correspondence to:
Professor J-F Colombel
Service d’Hépato-Gastroentérologie, Hôpital Huriez, CH et U Lille, 59037 Lille, France; jfcolombelchru-lille.fr
Citation
ITPA genotyping test does not improve detection of Crohn’s disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression
Publication history
- First published March 7, 2005.
Online issue publication
January 09, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Gut